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Abstract 
 
Methamphetamine is a widely abused psychostimulant often associated with aggressive, 
violent, and criminal behaviour.   Research into the effects of adolescent methamphetamine 
use on aggressive behaviour is limited.   This study aimed to establish whether 
methamphetamine would induce aggressive behaviour following an acute dosing regimen and 
a chronic dosing regimen.  It also aimed to establish a teratological or delayed effect on adult 
behaviour.  To investigate this 20 male and 20 female adolescent rats were equally divided 
into treatment and control conditions.  The treatment condition received a single dose of 
methamphetamine (2mg/kg) on postnatal day (PND) 35 followed by twice daily doses of 
methamphetamine (2mg/kg) from PND 36-46.  This was done via intraperitoneal injection.  
The control condition received comparable doses of saline.  Animals were tested using the 
resident intruder test following the single dose, after the completion of the final dose, and 
again in early adulthood (PND 90).  Results found an acute dosing regimen significantly 
reduced aggressive-like behaviour.  A chronic dosing regimen increased aggressive-like 
behaviour however, this relationship was less clear.  Finally, the results found increased 
aggressive behaviour in adult animals following methamphetamine use in adolescence.  This 
provides preliminary evidence for a teratological effect and support for the neuronal 
imprinting theory. 
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1.0 Introduction 
 
1.1 General Overview  
Adolescence is a vulnerable period in which an individual makes the transition from 
childhood to adulthood.  During this phase of development there is a dramatic increase in risk 
taking behaviour, including the initiation of substance use (Arnett, 1996).  Substance use 
during adolescence can have damaging effects on both the brain and behaviour.  These 
effects have been shown to outlast the substance use itself (Andersen & Navalta, 2004).  This 
is called a teratological effect.  There is currently insufficient research surrounding the 
behavioural effects of substance use when taken during adolescence.  For this reason there is 
a need to research the effects of these drugs with a strong emphasis on those substances that 
are commonly abused.   
 
Methamphetamine, an amphetamine derivative known as ice, meth, glass, shabu, or P, is a 
widely abused psychostimulant.  Research released by the Organized and Financial Crime 
Agency (Organized and financial crime agency New Zealand [OFCANZ], 2010) identified 
Oceania as having one of the highest amphetamine-type substance user rates per capita in the 
world.  In New Zealand young people, in conjunction with Maori and Pacific Islanders are 
alleged to be of greatest risk of encountering harm from methamphetamine use (New Zealand 
Police, 2009).  In 2001 in a sample aged 13-45 years 11% of individuals reported using 
amphetamines at least once in the past 12 months (Wilkins, Sweetsur, & Casswell et al., 
2006).  Use during adolescence, aged 15-19 years, increased from 4.0% to 7.5% between 
1998 and 2001 (Wilkins et al., 2006).  Methamphetamine use is as common in females.  In a 
sample of 350 American substance abusers over half, 56%, were female (Brecht, O‟Brien, 
Von Mayrhauser, & Anglin et al., 2004).   
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Methamphetamine, synthesized from pseudoephedrine or ephedrine, is taken for its euphoric 
and wakefulness effects (Tyner & Fremouw, 2008).  However chronic methamphetamine use 
can result in hostility, paranoia, hallucinations, and obsessive and aggressive behaviour (Hall 
& Hando 1994; Shearer, Sherman, Wodak, & Beek et al., 2002).  
 
Currently there is minimal scientific literature on the short-term and longer-term outcomes of 
methamphetamine use during adolescence. Therefore, the primary aim of this research was to 
provide an assessment of the short-term and longer-term behavioural effects, namely 
aggression, that result from repeated adolescent exposure to methamphetamine. 
 
1.2 Substance Use and Addiction 
To understand the possible outcomes of repeated exposure to methamphetamine, the 
diagnostic criteria for substance abuse and substance dependence disorder are described 
below.  Substance-related disorders can lead to significant personal, interpersonal, 
occupational, and social impairment. Substance abuse and substance dependence are two 
separate substance use disorders and these disorders are briefly described below.  The 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR; APA, 2000) is the 
leading tool for diagnosing these disorders.   
 
The DSM-IV TR defines substance abuse as a maladaptive pattern of substance use 
manifested by recurrent and significant adverse consequences related to the repeated use of a 
substance.  For a diagnosis the user must display at least one of four criteria in a 12 month 
period.  These include failure to fulfil major role obligations at work, school or home, 
repeated use in situations where it is physically hazardous, multiple legal problems, and 
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recurrent social and interpersonal problems.  The symptoms must not meet criteria for 
substance dependence disorder. 
 
Conversely the DSM-IV TR defines substance dependence as a cluster of cognitive, 
behavioural, and physiological symptoms indicating that the individual continues substance 
use despite significant substance-related problems.  For a diagnosis the user must display at 
least one of seven criteria in a 12 month period.  These include tolerance, withdrawal, taking 
larger amounts over a longer than intended period, persistent desire or unsuccessful effort to 
cut down or control use, and spending more time on activities necessary to obtain, use or 
recover from the substance.  See the DSM-IV TR for a full description of all symptoms; 
APA, 2000.  Before someone can have substance use disorder they must first undergo an 
experimentation phase with the drug.  Some possible reasons for experimentation are covered 
below. 
 
1.2.1 Initiation of Substance Use 
The initiation of substance use and its experimentation is a diverse and complex occurrence.   
Various risk factors may include, but are not limited to, genetic, environmental, biological, 
and psychological factors.  There is a large portion of literature reserved for the possible 
causes of substance use.  For the purpose of this study only genetic and environmental factors 
will be considered.   
 
Genetic and familial factors are biological characteristics that may impact on the initiation of 
substance use (Weinberg, Rahdert, Colliver, & Glantz, 1998).  Numerous studies of 
monozygotic and dizygotic twins have shown drug use to be highly heritable for substances 
such as marijuana, amphetamines, heroin, and cocaine (Xian et al., 2000; Tsuang et al., 
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1999).  Behavioural genetic research proposes that 40% to 60% of the vulnerability towards 
developing drug dependence is heritable (Button et al., 2006; Han, McGue, & Iacono, 1999).  
Using twin studies Tsuang et al., (1999) investigated the likelihood that respondents who 
were exposed to amphetamines would proceed from exposure to initiation of use to regular 
use.  This was done using conditional probabilities (Tsuang et al., 1999).  The conditional 
probability of making the transition from exposure to initiation of use was 0.44.  The 
conditional probability for the transition from initiation of use to regular use was 0.60 
(Tsuang et al., 1999).  These probabilities indicate that the process of moving from exposure 
to regular use is highly heritable for amphetamines.   
 
Environmental risk factors that may influence the initiation of substance use include low 
socio-economic status, family mental health problems, parental and older sibling drug use, 
lack of parental warmth, physical and sexual abuse, poor school performance, and peer 
pressure (Berk, 2006; Prinstein, Boergers, & Spirito, 2001).  Peer substances use is 
consistently found to be one of the highest predictors of substance use in adolescents 
(Hawkins, Catalano, & Miller, 1992).  In a sample of youth aged 10-15 perceived peer 
alcohol and marijuana use predicted the onset of marijuana use (D‟Amico & McCarthy, 
2006). 
 
Although research suggests many factors influence substance use it is commonly agreed that 
behaviours are the result of an interaction between numerous factors.  Substance use has the 
potential to escalate into drug dependence, of which the mechanisms of action are covered 
below. 
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1.2.2 Mechanisms of Addiction 
Drug addiction occurs when substance use shifts from being voluntary to being habitual and 
compulsive (Everitt & Robbins, 2005).  For a drug to lead to dependency it must first 
reinforce people‟s behaviour (Cardinal & Everitt, 2004; Carlson, 2007).  Initially it is positive 
reinforcement that mediates the effects of drugs.  Positive reinforcement refers to the effect 
that certain stimuli have on the behaviours that precede them (Carlson, 2007).  When 
behaviour, such as substance use, is regularly followed by an appetitive stimulus, such as 
pleasurable feelings or reduced stress, then that behaviour is reinforced and will occur more 
often.   
 
The process by which positive reinforcement influences substance abuse is through 
instrumental conditioning (Cardinal & Everitt, 2004).  This is the process by which behaviour 
is altered when there is a contingency between behaviour and a reinforcing outcome 
(Cardinal & Everitt, 2004).  Drugs act as reinforcers as they increase the likelihood of 
responses that produce them (Everitt & Robbins, 2005).  Drug abuse occurs initially because 
of its positive hedonic impact.  Additionally, stimuli consistently present in the drug taking 
environment gain motivational power due to their association with the drug.  These stimuli, 
such as drug paraphernalia, thereby elicit and support drug seeking and assist in relapse 
(Everitt & Wolf, 2002). 
  
Various neuroanatomical substrates are responsible for the reinforcing effects of substance 
use.  The neuronal pathways responsible for this are the same as those responsible for natural 
rewards such as food, drink, and sex (Cami & Farre, 2003).  It is proposed that most 
substances of abuse stimulate the release of dopamine from neurons in the brain (Carlson, 
2007).  These dopaminergic neurons responsible for reinforcement are located in the 
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mesocortical and mesolimbic dopamine systems which originate in the ventral tegmental area 
(Cami & Farre, 2003).  The mesolimbic system projects to limbic structures including the 
nucleus accumbens, amygdala and hippocampus.  This system is implicated in reinforcement, 
memory and the euphoric and addictive properties of substances (Cami & Farre, 2003; 
Carlson, 2007).  The mesocortical system projects from the ventral tegmental area to the 
prefrontal cortex, orbitofrontal cortex, and anterior cingulate.  The mesocortical system is 
involved in the conscious experience of the effects of substance use, craving, and the 
compulsion to take substances (Cami & Farre, 2003). 
 
The nucleus accumbens, located in the striatum, plays an important role in the reinforcing 
effects of stimuli (Cardinal & Everitt, 2004).  During substance use the release of dopamine 
into the nucleus accumbens causes euphoria and reinforcement (Cami & Farre, 2003).  
Research using positron emission tomography (PET) on human cocaine users showed a 
dramatic increase in dopamine transporters in the striatum (Volkow & Fowler, 2002).  
 
Once behaviour, such as substance dependence, has been established it must then be 
maintained.  This occurs via negative reinforcement (Carlson, 2007).  Negative reinforcement 
refers to when behaviour reduces an aversive stimulus.  For example, substance use reduces 
stress or anxiety (Cami & Farre, 2003).  In order to experience these negative effects of 
substances an individual must acquire tolerance to a substance and subsequently experience 
withdrawal effects. 
 
Tolerance refers to a state of progressively decreasing responsiveness to a drug (Julien, 
2001).  When a drug is taken more frequently larger doses of that drug are required in order 
to achieve the effects such as euphoria, originally obtained by a smaller dose.  There are two 
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main pharmacological mechanisms involved in the development of tolerance (Julien, 2001).  
These are metabolic tolerance and cellular-adaptive or pharmacodynamic tolerance.  In 
metabolic tolerance the enzyme responsible for metabolizing the drug increases and therefore 
more of the drug is required to maintain the same amount in the body.  In cellular-adaptive or 
pharmacodynamic tolerance receptors in the brain adapt to the presence of the drug.  This 
occurs via a process called down regulation whereby neurons adapt by either reducing the 
number of receptors available to the drug or by reducing their sensitivity. 
 
Once tolerance has been established the sudden removal of a drug will result in physical or 
psychological withdrawal effects (Carlson, 2007).  Withdrawal effects for any drug are 
commonly the opposite of the effects of the drug itself.  For example methamphetamine 
produces positive effects such as alertness, euphoria, and reduced appetite (Tyner & 
Fremouw, 2008).  However when consumption is ceased an individual will experience 
fatigue, depression and increased appetite.   These negative effects are only lessened by 
consuming the drug again.  However in doing so the drug removes these negative effects and 
is therefore negatively reinforcing the drug taking behaviour.  Withdrawal symptoms and 
tolerance share the same basic mechanism.  That is, they are the body‟s attempt to 
compensate for the drug and remain at an optimal level.  Both tolerance and withdrawal are 
essential for maintaining addiction (Cami & Farre, 2003).   
   
Substance use and dependence are serious disorders which can lead to significant 
impairment.  Substance use is reinforced via dopamine transporters in the mesocortical and 
mesolimbic systems.  The nucleus accumbens is especially implicated in the rewarding 
effects of substances.  Once substance use is acquired negative reinforcement, through 
tolerance and withdrawal, maintains it and drug use shifts to dependence.    
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1.3 Neurodevelopment: The Adolescent Point of Vulnerability 
Adolescence is the transitional phase from childhood to adulthood.  During this period certain 
developmental alterations are made in preparation for the transition from immaturity and 
dependence to maturity and independence (Spear, 2007).  Commonly the onset of puberty 
coincides with the beginning of adolescence. However, it is important to note that the two are 
not synonymous (Spear, 2000).  Puberty, or sexual maturation, is merely a specific 
developmental alteration that occurs as part of adolescence.  The brain continues to develop 
after sexual maturation has been met (Spear, 2000).  It is still unclear as to how long this 
adolescent brain development, known as the periadolescent period, continues.  The onset of 
the periadolescent period in humans spans from roughly 12 to 18 years of age and may 
extend up to 25 years (Spear, 2000).  The following sections will consider whether or not 
interference during this transitional period of brain development may have implications later 
in life.   
 
During the adolescent period there is a need to gain the appropriate skills for independence.  
In order to acquire growth adolescents partake in sensation seeking and risk taking 
behaviours (Arnett, 1992; Arnett, 1996).  Laviola, Adriani, Terranova, & Gerra (1999) 
suggest these traits are characterized by the continuing necessity to experiment with various 
novel and complex sensations.  Such behaviours include aggression and other antisocial 
behaviours, school misconduct, and substance use.  These types of behaviour are so common 
in adolescence that they are considered normal (Moffitt, 1993).  Although these behaviours 
do have benefits they also have negative consequences.   Specifically, research has shown 
that taking drugs during adolescence increases the risk of drug abuse and helps form long 
term abuse patterns in adulthood (Stansfield & Kirstein, 2006).   
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Adolescence is a time of considerable neural restructuring and sculpting of the brain 
(Luciana, 2010; Spear, 2007).  Brain regions responsible for basic functioning such as motor 
and sensory processes develop first (Casey, Tottenham, Listo, & Durston, 2005).  This is 
followed by the development of areas associated with the control of thoughts and actions 
(Casey et al., 2005).   
 
Neurodevelopment is evident in both cellular and anatomical structures (Carlson, 2007).  
Cellular development is marked by excessive synapse formation, receptors, and myelination.  
Neurons that are rarely stimulated lose their synapses in a process called synaptic pruning 
which occurs via apoptosis (Carlson, 2007).  Around 40% of synapses are lost during this 
process in order to reach the adult level (Berk, 2006).   
 
Anatomical structures that go through notable development include the prefrontal cortex, 
amygdala, nucleus accumbens, and hippocampus (Carlson, 2007).  Each of these structures 
serves a different purpose in brain functioning.  The prefrontal cortex is involved in 
formulating plans and strategies.  Specifically the growth of the prefrontal cortex in 
adolescence allows for the development of abstract reasoning, affect and judgement making.  
However the prefrontal cortex is not fully developed until later in life and therefore neither is 
the ability to make mature judgements (Chambers, Taylor, & Potenza, 2003).  The amygdala 
regulates emotional reactions. The nucleus accumbens is responsible for motivation, 
reinforcement, and addiction.  The hippocampus is responsible for memory formation.  
(Andersen, 2003; Carlson, 2007; Spear, 2000).  Research has also shown there to be sex 
differences in neurodevelopment.  For example, females in mammalian species mature more 
rapidly than males and human females reach peak levels of grey matter earlier than males at 
11.6 years versus 12.8 years (Andersen, 2003; Spear, 2000). 
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Exposure to drugs during the periadolescent phase alters the development of specific brain 
regions (Andersen & Navalta, 2004).  As a result there is a negative impact on normal 
development.  The below section will argue that substance use in this transitional phase can 
produce damaging consequences in adulthood.  
 
1.3.1 Neuronal Imprinting Theory 
Neuronal imprinting occurs when the effects of drug exposure outlast the drug itself 
(Andersen & Navalta, 2004).  It is the notion that the long term effects of drug exposure in 
adolescence are delayed and express themselves in adulthood (Andersen, 2003).  Specifically, 
drug exposure during adolescence alters the development of the particular brain regions 
where the drugs are active (Andersen & Navalta, 2004).  This is proposed to be caused by the 
„normal developmental trajectory‟ of the drug-affected brain circuit being altered in such a 
way that it differs from what would be predicted if the drug exposure had occurred in 
adulthood (Andersen & Navalta, 2004).  
 
As mentioned previously, adolescence is a developmental period when the brain is 
undergoing major neurological changes.  Drug exposure during this period will most likely 
have its greatest impact on brain regions that are undergoing active development.  This is 
compared to those brain regions that have reached their adult status (Anderson & Navalta, 
2004; Anderson 2003; Stansfield & Kierstein, 2003).  The effect of chronic drug use in 
adolescence occurs by integrating drug-induced changes into permanent developmental 
adjustment.  
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Neuronal imprinting has been shown to occur with a range of drugs including marijuana, 
nicotine, alcohol, and stimulants (Andersen, 2003).  One compelling example is that of 
exposure to methylphenidate in rats (Andersen, Arvanitogiannis, Pliakas, LeBlanc, & 
Carlezon, 2001).  After repeated administration of methylphenidate throughout adolescence 
the rats were tested in adulthood on place conditioning, a procedure in which rats learn to 
associate drug effects with particular environments.  Rats that were exposed to 
methylphenidate had a reduced responsiveness to cocaine‟s rewarding effects and an 
increased responsiveness to its aversive effects.  Rats not exposed to the drug had the 
opposite response to cocaine‟s effects.  A different sample of rats were treated with 
methylphenidate in adulthood and tested in later adulthood.  These rats did not show an 
aversive response to cocaine.  This research suggests that exposure to methylphenidate in 
adolescence, as compared to adulthood, has an enduring effect on brain and behaviour 
development.   
 
Considering the research, it is likely that adolescent exposure to methamphetamine may 
produce behavioural changes in adulthood.  These changes in adulthood would provide 
evidence for the neuronal imprinting theory.   
 
1.4 Methamphetamine 
Methamphetamine is a powerful psychostimulant belonging to the amphetamine class.  This 
central nervous system stimulant is taken by a wide range of people for its psychoactive 
effects.  Methamphetamine produces feelings of increased euphoria, focus, mental alertness, 
self esteem, confidence and reduced appetite (Anglin, Burke, Perrochet, Stamper, & Dawud-
Noursi, 2000; Darke, Kaye, McKetin, & Duflou, 2008).  Typical after-effects include 
depression, fatigue, sleep disturbance, headaches and cravings (Anglin et al., 2000; Darke et 
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al., 2008).  Methamphetamine is metabolized slower than other stimulants, such as cocaine, 
and produces these effects for up to 12 hours (Anglin et al., 2000).   
 
Repeated and chronic methamphetamine use is associated with paranoia, hallucinations and 
delusions of persecution, obsessive and aggressive behaviours (Hall & Hando 1994; Shearer 
et al. 2002).  In a New Zealand sample of 78 methamphetamine users the psychological 
problems commonly reported from frequent use were trouble sleeping (84%), short temper 
(58%), strange thoughts (56%), paranoia (55%), and anxiety (51%) (Wilkins, Girling, 
Sweetsur, & Butler, 2005).   
 
The rate of methamphetamine use is becoming increasingly problematic.  The estimated 
lifetime prevalence use in the United States of America for those aged 12 years and older is 
4.9% (Substance Abuse and Mental Health Services Administration, Office of Applied 
Studies [OAS], 2005).  However, little is known about the drug‟s long term effects and 
therefore more research is required to better understand the long term effects of adolescent 
exposure to methamphetamine.   
 
Methamphetamine was first synthesised in the 1887 in Germany from ephedrine, a common 
decongestant (Tyner & Fremouw, 2008).  Over many years methamphetamine has been used 
to treat narcolepsy, mild depression, postencephalitic parkinsonism, chronic alcoholism and 
obesity (Tyner & Fremouw, 2008).  During World War II American, Japanese, and German 
soldiers also used methamphetamine to maintain alertness (Tyner & Fremouw, 2008).   
During the 1980‟s methamphetamine became a commonly abused drug of choice and was 
used by a wide variation of people (Cartier, Farabee & Prendergast, 2006).  Media reports 
soon emerged linking the drug to aggression, violence, and crime despite there being a lack 
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of literature to suggest this.  Legal restrictions were implemented throughout the 1980‟s along 
with restricted access to products containing ephedrine.   
 
The principle mechanisms of action for methamphetamine are very similar to those for 
cocaine.  Amphetamines, including methamphetamine, stimulate the release of synthesized 
catecholamines in the CNS (Homer et al., 2008).  Amphetamines cause neuronal storage 
vesicles to release dopamine, norepinephrine, and serotonin neurotransmitters into the 
synapse (Homer et al., 2008).   Amphetamines then inhibit the uptake of these 
neurotransmitters by membrane transporters as well as inhibiting monoamine oxidase (Homer 
et al., 2008).  Although the serotonin transporter is involved dopamine and norepinephrine 
transporters are the most influenced.  In vitro studies of chronic methamphetamine users 
found reduced levels of dopamine, tyrosine hydroxylase and dopamine transporter (DAT) in 
the nucleus accumbens, caudate nucleus, and putamen (Wilson et al., 1996).  In vivo studies 
have found detoxified methamphetamine users to have reduced DAT, and Dopamine D2 
receptor binding in the caudate, putamen, accumbens and prefrontal cortex (Volkow et al., 
2001; Volkow & Fowler, 2001).  Another in vivo study using PET scans found abstinent 
methamphetamine users had reduced serotonin levels in the CNS (Sekine et al., 2006). 
 
A growing number of studies now show that methamphetamine is highly neurotoxic (Homer 
et al., 2008).  Various anatomical toxicities have been reported in the limbic system, such as 
reduced hippocampus size, white matter replacing grey matter, corpus callosal changes, and 
reduced levels of presynaptic dopamine and serotonin transporters (See Barr et al., 2006, for 
a review).  These anatomical changes correlate with behavioural changes that persist long 
after drug cessation.  For example damage to the dopamine and serotonin systems would 
have wide ranging neural and behavioural effects as these neurotransmitters play a vital role 
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in physiological and behavioural systems including regulating mood, anxiety and behaviour, 
such as aggression.  Dopamine, norepinephrine, and serotonin also constitute a reward system 
in the brain that influences abuse potential.  The neurotoxicity findings of methamphetamine 
suggest it may produce a neuronal imprinting effect.  
 
Methamphetamine is acknowledged to be among one of the most addictive substances known 
and has high levels of abuse potential (Rothman & Baumann, 2003).  Methamphetamine has 
been shown to induce conditional place preference and to elicit self-administration of the 
drug.  Taylor and Horger (1999) studied the reinforcing properties of amphetamines in male 
rats previously trained to self-administer cocaine and found amphetamine acted as a reliable 
reinforcer.  There was a five-fold increase in the self-administration of methamphetamine, via 
cannula placements in the nucleus accumbens, in cocaine pre-treated versus control rats.  
Mendrek, Blaha, and Phillips (1997) studied whether pre exposure to methamphetamine 
would enhance the motivation to self administer methamphetamine.  Using a fixed-ratio 
schedule methamphetamine pre-treated rats self administered methamphetamine more so than 
controls.   
 
Research on the short-term and longer-term outcomes of repeated adolescent exposure to 
methamphetamine is very limited.  Research by Shintomi (1975) measured the short-term 
effects of methamphetamine in seven adult male rats.  The study showed that hyperactivity 
and fighting were increased when rats were administered a higher dose of 5 mg/kg versus a 
lower dose of 2.5 mg/kg.  These behaviours were apparent 20 minutes after a subcutaneous 
injection and diminished after 60 minutes.  A more recent study by Sokolov, Schindler, and 
Cadet (2004) compared the short-term and longer-term effects of exposure to 
methamphetamine using adult male mice.  Their research showed that mice treated 
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chronically with increasing twice daily injections over 8 weeks (up to 6 mg/kg each) showed 
significantly more fighting behaviour (83%) than those treated with one acute intraperitoneal 
injection (6 mg/kg) of methamphetamine (25%).  Sokolov et al., (2004) employed the 
resident intruder paradigm to measure aggression.   
 
Although both studies mentioned above demonstrate aggressive behaviour after exposure to 
methamphetamine this was done using small numbers of adult male rats and mice.  However, 
a local study by Johnson (2010) has provided some preliminary results using adolescent male 
and female rats.  In his study, adolescent rats of both sexes were administered 1 or 2 mg/kg of 
methamphetamine and subsequently tested for aggression.  The research found that an acute 
dosing regimen did not significantly increase aggression when compared to controls.  This 
study highlighted the short-term effects of adolescent exposure to methamphetamine.  It is 
then possible to extend this study and measure the long-term outcomes of adolescent 
exposure to methamphetamine.   
 
Methamphetamine is a commonly abused psychostimulant being consumed by New Zealand 
adolescents.  Methamphetamine has a high abuse potential and is regarded as being one of the 
most addictive substances.  However there remains a lack of research regarding both the 
short-term and longer-term outcomes of methamphetamine use in this demographic.   
 
1.5 Aggression 
Methamphetamine has been closely linked to aggressive behaviour (Baskin-Sommers & 
Sommers, 2006; Boles & Miotto, 2003; Cartier et al., 2006; Herring, Schaefer, Gudelsky, 
Vorhees, & Williams, 2008; Homer et al., 2008; McCormick &Smith, 1995; McEllistrem, 
2003; Sheridan et al., 2004; Sokolov et al., 2004; Sommers & Baskin, 2006; Zweben et al., 
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2004).  Methamphetamine users are described as being high risk offenders due to their 
frequent and erratic violent behaviour (Tyner et al., 2008).  In a New Zealand sample of 78 
frequent users 23% reported experiencing violent behaviour from their methamphetamine use 
(Wilkins et al., 2005).  In another sample of 137 regular methamphetamine users in New 
Zealand, 42% had committed a violent crime in their lifetimes (Wilkins, Griffiths, & 
Sweetsur, 2009).  A study by Sommers and Baskin (2006) found that 27% of 
methamphetamine users had engaged in violent behaviour while under the influence of 
methamphetamine.  They found 51% of these incidents occurred within domestic 
relationships and 29% were drug related. Incidents also included random acts of violence and 
gang-related violence. 
 
Although methamphetamine is commonly associated with aggression and violence, this 
relationship still remains poorly understood.  McKetin and colleagues (2006) proposed that 
this relationship is credible for three reasons.  Firstly, experimental evidence suggests that 
chronic use may increase aggressive behaviours. Secondly, an acute dose may enhance an 
aggressive response if someone is provoked.  Finally, methamphetamine use increases the 
likelihood of psychosis which itself is associated with aggressive behaviours.   
 
Research commonly agrees that there are two primary modes of aggressive and violent 
behaviour.  These are affective and predatory aggression (McEllistrem, 2003).  This study 
will focus on the former.  Affective defence is an aggressive response based upon the 
presence of fear and or threat that may be real or perceived.  The goal is to reduce or 
eliminate the threat object from the environment.  This form of aggression occurs in humans 
and animals.   
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Research suggests aggression is biological in nature with neurotranmitters including 
GABAergic, serotonergic, noradrenergic and dopaminergic systems being strongly 
implicated (McEllistrem, 2003).  Recent research has suggested increased aggression in 
humans occurs via serotonin depletion.  In a recent study by Sekine et al. (2006) chronic 
methamphetamine users were found to have both higher levels of aggression than non-drug 
using controls and decreased levels of serotonin in areas of the brain that are involved in the 
regulation of aggression, including the orbitofrontal cortex, anterior cingulate cortex, and 
temporal cortex.   Sekine and colleagues (2006) also found that the level of serotonin 
depletion in these areas of the brain correlated with the magnitude of aggression among 
methamphetamine users.  There is also support for the role of cognitive, behavioural, and 
environmental factors (Weinshenker & Siegal, 2002).  Boles and Miotto (2003) report the 
pharmacological effects of methamphetamine, such as agitation, paranoia and psychosis, and 
the systemic violence factors are responsible for aggression.   
 
The resident intruder test measures territorial aggression.  That is, aggression that occurs 
when an intruder enters into an area that an animal has determined to be its own domain 
(Weinshenker & Siegal, 2002).  The test was formulated specifically to engender agonistic 
behaviour in laboratory rats (Miczek, 1979).  Aggressive behaviours seen in the test are 
similar to those seen in humans, including bite attacks, threats, defence, submission, and 
flight.  The resident intruder test has been effectively used to measure aggressive behaviours 
in rats, mice, humans and hamsters (Ferris et al., 1997; Johnson, 2010; Malkesman, Maayan, 
Weizman, &Weller, 2006; Miczek, 1978; Miczek, & O‟Donnell, 1978; Ogawa, Lubahn, 
Korach, & Pfaff, 1997; Sokolov & Cadet, 2006). 
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1.7 Present Study 
The present study investigated the short-term and long-term behavioural effects of adolescent 
exposure to methamphetamine.  On post natal day (PND) 35 male and female rats were 
treated with a single dose of methamphetamine (2 mg/kg) or saline.  From PND 36-46 the 
rats were treated with twice daily doses of methamphetamine (2 mg/kg) or saline.  Subjects 
were tested after the initial dose, after the completion of the final dose and again in early 
adulthood (PND 90) in a resident intruder test.  Sex differences in behaviour were recorded 
because of sex differences in brain maturation (Andersen, 2003).  As male and female brains 
develop differently, exposure to methamphetamine is likely to affect each sex differently in 
the long-term. 
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2.0 The Aims and Hypotheses of this Study 
 
The aim of this research was to provide an original contribution to the scientific literature 
regarding the short-term and long-term outcomes of adolescent exposure to 
methamphetamine.  To date there has been a lack of literature regarding methamphetamine 
use in adolescence.  This is an important cohort to examine not only because of the 
immediate consequences of abusing methamphetamine but also because of the potential long-
term consequences. 
 
Aggression was specifically studied as this behaviour is strongly associated with 
methamphetamine use, both in the literature and the media.   
 
It was expected that aggressiveness would increase with a longer exposure to 
methamphetamine use in adolescence.  That is, an acute dosing regimen of methamphetamine 
would have little effect on aggressiveness.  This would support previous research suggesting 
that a single dose of methamphetamine does not increase aggressive behaviour.  It was 
expected that a chronic dosing regimen of methamphetamine would increase aggressiveness.  
This finding would be consistent with previous research and society‟s belief that 
methamphetamine produces aggression and crime.  It was also expected that 
methamphetamine use during adolescence would increase aggressiveness in adulthood.  The 
demonstration of a teratological effect would provide further support for the neuronal 
imprinting theory and the neurotoxicity of methamphetamine.   
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3.0 Method 
 
3.1 Subjects 
Subjects were 40 male and 40 female PVG/C hooded rats from the Animal Facility, 
Department of Psychology, University of Canterbury, New Zealand.  On post natal day 
(PND) 30, the pups were weaned and caged in 475 x 280 x 230 mm plastic cages in groups of 
two to four of the same sex.  The temperature and humidity were controlled (rh 22°C ± 2°C 
and rh 48% ± 10%, respectively) on a 12 hour light/dark cycle (lights on at 0800).  All 
animals had free access to water and food (commercial rat pellets) for the duration of the 
study.  All subjects and procedures were approved by the University of Canterbury Animal 
Ethics Committee (see Appendix A). 
 
On PND 30, the 80 subjects were randomly assigned to an intruder group, a control group 
and a treatment group.  The intruder group consisted of 20 males and 20 females and 
remained housed in groups of two to four for the duration of the experiment.  These rats were 
used only for testing purposes and received no treatment.  The control and treatment groups 
consisted of 10 males and 10 females each.   They were separated into individual cages (of 
the same measurement) on PND 30 until treatment and testing had been completed on PND 
46.  One PND 46 they were re-caged in groups of two to four until PND 83 when they were 
separated again into individual cages.   
 
On PND 35 subjects were administered one dose of saline or methamphetamine.  From PND 
36 to 46 subjects were administered two daily doses of saline or methamphetamine.  All 
doses were administered at 0900 and 1500 hours.  The age of drug exposure was selected to 
represent the periadolescent stage of development in rats (Spear, 2000).  The subjects were 
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tested behaviourally for aggression on PND 35, 20 minutes after treatment, on PND 46, 20 
minutes after the final treatment, and on PND 90.  Testing at PND 35 enabled examination of 
the effects of an acute dosing regimen in early adolescence.  Testing at PND 46 enabled 
examination of the effects of a chronic dosing regimen in late adolescence.  Testing at PND 
90 enabled adult assessment of behavioural effects of methamphetamine exposure in 
adolescence, after a long period without drug.  These three stages will be referred to as acute 
effects, chronic effects, and teratological effect in the results section of this report.  
 
3.2 Drugs and Rationale for Doses  
Methamphetamine was donated in a pure form crystal by Environmental Science & Research 
Limited (ESR, Wellington, New Zealand).  The crystals were crushed and dissolved in sterile 
0.9% saline to produce a dose of 2 mg/kg.   On PND 35, animals in the control and treatment 
group received an intraperitoneal (i.p.) injection of either saline or methamphetamine, in a 
volume of 1 mg/kg.  From PND 36 to 46 the same animals received two daily i.p. injections 
of either saline or methamphetamine.  Hence on day 1 the treatment animals received 2 
mg/kg of methamphetamine and every day there after (for a further 10 days) they received a 
total of 4 mg/kg daily.  This resulted in a cumulative dose of 42 mg/kg.  Control animals 
received the same amount of saline.  Treatment at day 1 represented an acute dosing regimen.  
Treatment for the total 11 days represented a chronic dosing regimen (see Table 1).  
Intraperitoneal administration was selected for ease of drug delivery.  The animals‟ body 
weights were recorded prior to each injection and injection volumes were adjusted 
accordingly.  
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Table 1. Days of treatment with methamphetamine (METH mg/kg) or saline (S) from PND 35 for 20 male and 20 female rats. 
Group 
Days of  
METH 
Treatment 
 
1 2 3 4 5 6 7 8 9 10 11 
Total 
METH 
Exposure 
Intruder 
(Male, 
20) 
0 No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx 0 mg/kg 
Intruder 
(Female, 
20) 
0 No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx No Tx 0 mg/kg 
Control 
(Male, 
10) 
0 S S+S S+S S+S S+S S+S S+S S+S S+S S+S S+S 0 mg/kg 
Control 
(Female, 
10) 
0 S S+S S+S S+S S+S S+S S+S S+S S+S S+S S+S 0 mg/kg 
METH 
(Male, 
10) 
11 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
42 mg/kg 
METH 
(Female, 
10) 
11 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
METH 
(2) + 
METH 
(2) 
42 mg/kg 
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The acute dose of 2 mg/kg was based on a recent study completed at Canterbury University 
assessing aggression in rats treated with a single dose of methamphetamine (Johnson, 2010).  
A dose of 4 mg/kg per day (given in two 2 mg/kg doses) was selected for the chronic dosing 
regimen in this study as it represented a low to medium dose of methamphetamine.  In earlier 
research, doses of methamphetamine shown to be behaviourally effective have ranged from 
as low as 2 mg/kg per day to as high as 30 mg/kg per day (Brennan et al., 2007, Sokolov, 
2004; Vorhees, 2005).  For example, a medium dose of 5 mg/kg per day was shown to 
produce increased levels of fighting behaviour (Shintomi, 1975).  Due to high neurotoxicity a 
multiple-day dosing procedure of two or four doses of methamphetamine per day, is 
generally used for all chronic dosing regimens (Vorhees, 2005).   
 
3.3 Apparatus and Behavioural Measures 
This experiment made use of an empirically-supported test of aggressive-like behaviour, the 
resident intruder test.  In the resident intruder test, a more aggressive animal will take less 
time to initially bite and display more bite attacks, allogrooming, anogenital contact, boxing, 
pursuit, and pinning directed at another animal.  A more aggressive animal will also display 
more offensive sideways posture and mutual upright posture.  
 
The experimental room was controlled at 22°C ±2°C, 48% ±10% humidity and 44 lx dim 
lighting. All testing took place between 0900 and 1800 hours during the light phase of the 
animals‟ light/dark cycle.  Previous research had indicated that changing bedding shortly or a 
few days before testing almost completely eliminated any significant findings as the animals 
become less territorial.  Therefore, tests were completed on day 6 or 7 after changing bedding 
(Sokolov et al., 2003) 
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To control for habituation effects the test was completed three times, each with a significant 
period of time separating them.  Testing following the chronic dosing regimen occurred 10 
days after testing following the acute dosing regimen.  Testing in early adulthood on PND 90 
occurred 44 days after testing following the chronic dosing regimen.  In addition each animal 
treated with methamphetamine or saline was never tested against the same intruder animal 
more than once.  
 
3.31 Resident Intruder Test 
The resident intruder test reliably measures agonistic behaviour without the use of aversive 
manipulations such as shock, food deprivation and brain surgery (Miczek, 1979).  A more 
aggressive animal will display more agonistic behaviour towards the intruder animal.  The 
resident intruder test was conducted in the residents‟ home cage where it had been singly 
housed for 5 to 6 days prior.  The plastic cages measured 475 x 280 x 230 mm and were 
illuminated by dim (44 lx) fluorescent lighting, 1,390 mm above the cage.  The lids of the 
home cages were removed during the test.  The intruder animal was introduced into the home 
cage, 20 minutes following injection, for 15 minutes (900 seconds).  Timing began as soon as 
the intruder animal touched the bottom of the home cage.   
 
Latency before the first bite attack was recorded and was assumed to be 900 seconds where 
no bite attack occurred. Other behaviours recorded included the frequency of bite attacks, 
allogrooming, anogenital contact, pinning, pursuit, lunging, escapes, offensive sideways 
posture, mutual upright posture, and boxing and kicking (measured as one).  Boxing and 
kicking were measured as one behaviour as they were deemed to be very similar. Boxing 
involved the use of the animal‟s front legs and kicking involved the use of the animals back 
legs.  In a previous study only boxing had been measured (Malkesman et al., 2006) however 
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kicking occurred just as frequently.  The categories of aggressive behaviour are described 
below;  
 Latency to first bite attack – time elapsed before the first bite attack. 
 Bite attack – resident rat bites intruder rat. 
 Allogrooming – resident rat aggressively grooms (involving teeth) around the 
intruder‟s shoulder and neck area. 
 Anogenital contact – resident rat sniffs the anogenital region of the intruder. 
 Pinning – resident rat places intruder rat in a supine position and releases contact with 
the ground with at least two paws. 
 Boxing and kicking – resident rat boxes with front paws or kicks with hind paws 
(behaviour is still counted if no contact is made). 
 Pursuit – resident rat chases intruder rat around the cage. 
 Offensive sideways posture – resident rat rears on hind legs over the intruder rat who 
is in a submissive posture or lying on side with eyes closed. 
 Mutual upright posture – both rats stand on hind legs and face one another. 
 
If intervals between the occurrences of two aggressive acts exceeded 3 seconds the two 
behavioural acts were scored as two separate aggressive acts (Ogawa et al., 1997).  A 3 
second timer, regularly tested for accuracy, was used throughout the resident intruder test. 
 
If one of the animals were deemed to be overly distressed or injured they were separated for a 
few seconds, and then the test was continued.  This was done by removing the intruder rat 
from the test cage and placing it back into the home cage.  
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Each treatment animal completed the test three times.  This was after the acute dosing 
regimen, after the chronic dosing regimen, and again at PND 90.  In the former cases testing 
occurred 20 minutes after the appropriate treatment had been given (Shintomi, 1975).  To 
control for habituation effects the treatment animals were not exposed to the same intruder 
more than once.    
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4.0 Statistical Analyses 
 
All raw data were analysed by separate 2(treatment) x 2(sex) analyses of variance 
(ANOVA‟s) using the Statview statistical programme.  The ANOVA‟s were performed on 
each measure at each of the three testing periods.  Methamphetamine treatment effects are 
presented in graphical form as means ± standard error of the means (SEM‟s) (See Figures 1-
9).  Due to sex differences in brain development it seemed likely that each sex might express 
aggressive behaviour differently over the course of the study.  Sex differences were examined 
using averages of both trials, and the results are presented in tabular form.  There were no 
significant treatment x sex interactions. 
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5.0 Results 
 
5.1 Effects of Methamphetamine Treatment 
5.1.1 Acute Effects 
Figures 1, 2, and 3 below show the level of each aggressive behavioural measure after the 
acute dosing regimen of methamphetamine or saline in early adolescence.  As shown in 
Figure 1A below, the methamphetamine group took significantly longer to bite than controls 
after an acute testing regime F(1,36) = 37.29, p<.0001.  This indicates the control group 
showed significantly more aggressive behaviour than the methamphetamine group.  Figure 
1B and 1C shows the control group performed significantly more bite attacks and 
allogrooming than the methamphetamine group F(1,36) = 43.48, p<.0001, and F(1,36) = 
73.25, p<.0001 respectively.  These results indicate significantly more aggressive behaviour 
in the control group.  
 
 
Figure 1. A. Latency to bite (in seconds), B. Frequency of bite attacks, and C. Frequency of allogrooming  
for control (n=20) and methamphetamine (n=20) groups as measured in early adolescence.  The error 
bars show standard errors of the means. *significantly different from control group (p<.05).  
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Below Figure 2A and 2B shows the control group made significantly more anogential contact 
than the methamphetamine group F(1,36) = 26.53, p<.0001 and performed significantly more 
pinning F(1,36) = 38.76, p<.0001 after the acute administration. Figure 2C shows the control 
group displayed only slightly more boxing and kicking than the methamphetamine group.  
This difference was not significant F(1,36) = 1.8, p<.188.   
 
 
Figure 2. A. Frequency of anogenital contact, B. Frequency of pinning, and C. Frequency of boxing and 
kicking for control (n=20) and methamphetamine (n=20) groups as measured in early adolescence.  The 
error bars show standard errors of the means.  *significantly different from control group (p<.05). 
 
As shown in Figure 3A the control group engaged in significantly more pursuit than the 
methamphetamine group F(1,36) = 38.66, p<.0001.  Figure 3B shows the control group 
displayed more offensive sideways posture than the methamphetamine group, but this 
difference was not significant F(1,36) = 1.59, p<.215.  Figure 3C shows the control group 
displayed significantly more mutual upright posture than the methamphetamine group 
F(1,36) = 21.16, p<.0001. 
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Figure 3. A. Frequency of pursuit, B. Frequency of offensive sideways posture, and C. Frequency of 
mutual upright posture for control (n=20) and methamphetamine (n=20) groups as measured in early 
adolescence.  The error bars show standard errors of the means.  *significantly different from control 
group (p<.05). 
 
Overall the results suggest that, following an acute dosing regimen, the control group 
displayed significantly more aggressive behaviour than the methamphetamine group.  The 
difference between the two groups was significant for all measures of behaviour except for 
boxing and kicking, and offensive sideways posture.  
 
5.1.2 Chronic Effects 
Figure 4, 5, and 6 below show the level of each aggressive behaviour following the chronic 
dosing regimen when tested in late adolescence.  Figure 4A shows the methamphetamine 
group took longer to initially bite than the control group indicating reduced aggression.  
However this difference was not significant F(1,36) = 3.13, p<.085.  Figure 4B and 4C show 
the control group displayed significantly more aggressive behaviour than the 
methamphetamine group performing significantly more bite attacks F(1,36) = 5.24, p<.028 
and allogrooming F(1,36) = 19.68, p<.0001. 
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Figure 4. A. Latency to bite (in seconds), B. Frequency of bite attacks, and C. Frequency of allogrooming  
for control (n=20) and methamphetamine (n=20) groups as measured in late adolescence.  The error bars 
show standard errors of the means.  *significantly different from control group (p<.05). 
 
Figure 5A and 5B show the control group performed significantly more anogential contact 
F(1,36) = 4.6, p<.0388, and pinning F(1,36) = 4.47, p<.0415 after a chronic testing regime.  
Figure 5C demonstrates the methamphetamine group performed significantly more boxing 
and kicking than the control group when tested in late adolescence F(1,36) = 12.51, p<.001.   
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Figure 5. A. Frequency of anogenital contact, B. Frequency of pinning, and C. Frequency of boxing and 
kicking for control (n=20) and methamphetamine (n=20) groups as measured in late adolescence.  The 
error bars show standard errors of the means.  *significantly different from control group (p<.05). 
 
Below, Figures 6A and 6B show the control group performed more aggressive behaviour than 
the methamphetamine group but this was not significant for pursuit F(1,36) = 3.11, p<.0864 
and offensive sideways posture F(1,36) = 1, p<.324.  Figure 6C shows the methamphetamine 
group performed more aggressive behaviour than controls, but, again this was not significant 
F(1,36) = 2.19, p<.147.   
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Figure 6. A. Frequency of pursuit, B. Frequency of offensive sideways posture, and C. Frequency of 
mutual upright posture for control (n=20) and methamphetamine (n=20) groups as measured in late 
adolescence.  The error bars show standard errors of the means.  *significantly different from control 
group (p<.05). 
 
The above results show a trend towards the control group displaying more aggressive 
behaviour than the methamphetamine group.  However, these findings are not consistent 
across all or most behaviours assessed and many differences did not reach statistical 
significance.  Overall, the results suggest that, with the exception of boxing & kicking, and 
mutual upright posture chronic treatment with methamphetamine appeared to decrease (rather 
than increase) aggressive behaviour.  However this decrease was less clear than the decrease 
seen following the acute dosing regimen.  
 
5.1.3 Teratological Effects 
Figures 7, 8, and 9 below demonstrate the level of aggressive behaviour when the groups 
were assessed in early adulthood after receiving both acute and chronic dosing regimen in 
adolescence.  Figure 7A below shows the methamphetamine group took significantly less 
time to initially bite than the control group F(1,36) = 4.2, p<.0478.  This indicates increased 
aggression in the methamphetamine group.  In figure 7B the methamphetamine group 
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showed a significantly greater number of bite attacks than the controls F(1,36) = 4.96, 
p<.0324.  Figure 7C shows the methamphetamine group performed significantly more 
allogrooming than controls F(1,36) = 20.87, p<.0001.   
 
 
Figure 7. A. Latency to bite (in seconds), B. Frequency of bite attacks, and C. Frequency of allogrooming  
for control (n=20) and methamphetamine (n=20) groups as measured in early adulthood.  The error bars 
show standard errors of the means.  *significantly different from control group (p<.05). 
 
As seen below, Figures 8A and 8B show the methamphetamine group displayed more 
aggressive behaviour than the control group, and performed significantly more anogenital 
contact F(1,36) = 17.73, p<.0002, and pinning F(1,36) = 41.5, p<.0001.   Figure 8C shows 
there was a marginal difference between the groups for boxing and kicking F(1,36) = 3.86, 
p<.0573.  
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Figure 8. A. Frequency of anogenital contact, B. Frequency of pinning, and C. Frequency of boxing and 
kicking for control (n=20) and methamphetamine (n=20) groups as measured in early adulthood.  The 
error bars show standard errors of the means.  *significantly different from control group (p<.05). 
 
Figures 9A and 9C show the methamphetamine group engaged in significantly more pursuit 
F(1,36) = 4.5, p<.0408 and mutual upright posture F(1,36) = 32.5, p<.0001, than the controls.  
Figure 9B shows the methamphetamine group displayed more offensive sideways posture 
than controls, but this was not significant F(1,36) = 1, p<.324.  
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Figure 9. A. Frequency of pursuit, B. Frequency of offensive sideways posture, and C. Frequency of 
mutual upright posture for control (n=20) and methamphetamine (n=20) groups as measured in early 
adulthood.  The error bars show standard errors of the means.  *significantly different from control 
group (p<.05). 
 
Overall the above the results suggest that the methamphetamine group displayed significantly 
more aggressive behaviour than the control group when assessed in early adulthood.  These 
findings suggest support for a teratological effect.  
 
5.2 Sex Effects 
Table 2 below shows sex effects for all measures of aggressive behaviour.  There were only 
two behaviours that were found to have a significant sex effect.  Females performed 
significantly more boxing and kicking F(1,36)=4.17, p<.05, and offensive sideways posture 
F(1,36)=5.44, p<.05.  For the most part, there was very little difference between the rate of 
male and female aggressive behaviour.  
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Table 2.  Means (standard error of the mean) and results of F tests for latency to bite and frequency of 
bite attacks, allogrooming, anogenital contact, boxing, pinning, pursuit, offensive sideways posture and 
mutual upright posture for male (n=20) and female (n=20) rats at the three different testing ages (acute, 
chronic and teratological).  * indicates a significant sex effect.  
Acute Treatment Male Female   F P 
  (n=20) (n=20)   (1,36)   
      Latency to Bite 530.20 (67.94) 507.80 (78.94) 
 
0.05 n.s.  
Bite Attacks 2.90 (0.74) 4.90 (1.40) 
 
1.59 n.s.  
Allogrooming 11.25 (2.77) 11.75 (2.48) 
 
0.02 n.s.  
Anogenital Contact 8.00 (1.90) 11.85 (2.34) 
 
1.63 n.s.  
Boxing & Kicking 5.05 (1.12) 6.10 (1.31) 
 
0.38 n.s.  
Pinning 1.75 (0.59) 3.55 (0.99) 
 
2.44 n.s.  
Pursuit 1.25 (0.42) 1.65 (0.48) 
 
0.40 n.s.  
Offensive Sideways Posture 0.90 (0.26) 1.50 (0.46) 
 
1.31 n.s.  
Mutual Upright Posture 1.85 (0.53) 1.55 (0.44) 
 
0.19 n.s.  
      Chronic Treatment Male Female   F P 
  (n=20) (n=20)   (1,36)   
      Latency to Bite 362.45 (67.16) 354.60 (68.17) 
 
0.01 n.s.  
Bite Attacks 4.00 (0.84) 6.15 (1.47) 
 
1.61 n.s.  
Allogrooming 13.75 (2.50) 13.00 (2.63) 
 
0.04 n.s.  
Anogenital Contact 14.90 (2.68) 21.70 (3.08) 
 
2.77 n.s.  
Boxing & Kicking 16.65 (3.79) 25.85 (5.34) 
 
1.98 n.s.  
Pinning 1.30 (0.36) 2.30 (0.49) 
 
2.70 n.s.  
Pursuit 0.75 (0.25) 1.55 (0.53) 
 
1.86 n.s.  
Offensive Sideways Posture 1.15 (0.34) 2.65 (0.69) 
 
3.76 n.s.  
Mutual Upright Posture 3.85 (0.93) 3.90 (1.03) 
 
0.00 n.s.  
      Teratological Effects Male Female   F P 
  (n=20) (n=20)   (1,36)   
      Latency to Bite 841.15 (36.12) 696.90 (65.50) 
 
3.72 n.s.  
Bite Attacks 0.20 (0.12) 0.70 (0.31) 
 
2.29 n.s.  
Allogrooming 4.20 (0.94) 4.65 (1.32) 
 
0.08 n.s.  
Anogenital Contact 17.85 (2.18) 23.55 (2.46) 
 
3.00 n.s.  
Boxing & Kicking* 2.20 (0.55) 5.40 (1.47) 
 
4.17 <.05 
Pinning 1.10 (0.30) 1.25 (0.38) 
 
0.10 n.s.  
Pursuit 0.10 (0.07) 0.10 (0.07) 
 
0.00 n.s.  
Offensive Sideways Posture* 0.00 (0) 0.35 (0.15) 
 
5.44 <.05  
Mutual Upright Posture 1.15 (0.30) 1.85 (0.46) 
 
1.62 n.s.  
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6.0 Discussion of Results 
 
The present study exposed adolescent rats to either saline or methamphetamine.  Both groups 
received treatment throughout the adolescent stage of development (PND 35 – PND 46).  On 
PND 35 the methamphetamine group received one initial 2 mg/kg i.p injection of 
methamphetamine.  For a further 10 days (PND 36-46) the methamphetamine group received 
2 mg/kg i.p. injections twice daily.  The control group received comparable doses of saline on 
the same days. The rats were subsequently tested in one empirically validated measure of 
aggression after the acute dosing regime in early adolescence, after the completion of the 
chronic dosing regime in late adolescence, and again in early adulthood when possible 
behavioural teratological effects of the drug were assessed. 
 
6.1 Summary of Results 
The results revealed a variation of differences in the drug treated animals and saline controls.  
This means that exposure to methamphetamine influenced the aggressive-like behaviour of 
the animals in some, but not all measures of the resident intruder test.  The results are 
summarized below.   
 
Acute methamphetamine exposure in early adolescence significantly reduced or had no effect 
on aggressive-like behaviour when compared to controls.  That is, an acute dosing regimen of 
methamphetamine, when compared to saline, significantly reduced aggressive-like behaviour 
for measures of latency to bite, bite attacks, allogrooming, anogenital contact, pinning, 
pursuit, offensive sideways posture, and mutual upright posture.  The methamphetamine-
treated and control animals preformed a similar amount of boxing and kicking. 
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Chronic exposure to methamphetamine during adolescence significantly decreased several 
measures of aggressive-like behaviour, but not all.  Animals administered a chronic dosing 
regimen of methamphetamine performed significantly more boxing and kicking.  They also 
performed marginally more bite attacks and mutual upright posture than controls.  However, 
controls performed significantly more allogrooming, anogenital contact, and pinning.  
Controls also performed more pursuit and offensive sideways posture, however these were 
not significant.  There was no significant effect for latency to bite, however the 
methamphetamine group did take longer, indicating less aggression than controls.   
 
These findings suggest that an acute dosing regimen may not produce aggressive-like 
behaviours.   A chronic dosing regimen may influence aggressive-like behaviours to some 
degree, however this relationship is unclear.  Nevertheless, the results do suggest some 
support for the main hypothesis, namely that aggressiveness, in adolescence, would increase 
with a longer exposure to methamphetamine. 
 
The second aim of this research was to establish whether exposure to methamphetamine 
would have long term behavioural teratological effects.  Adult animals that were exposed to 
methamphetamine during adolescence displayed a degree of aggressive-like behaviours.  The 
methamphetamine-treated group, compared to controls, engaged in significantly more 
allogrooming, anogenital contact, pinning, pursuit and mutual upright posture.  The 
methamphetamine group also took significantly less time to initially bite, compared to 
controls.  The frequency of bite attacks, boxing and kicking, and offensive sideways posture 
were similar for both the treated and control animals.  The findings from these measures 
support the possibility that methamphetamine use during adolescence can increase 
aggressiveness in adulthood. 
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6.1.1 Sex Differences  
Overall, this research found little evidence of differences in aggressive behaviour between 
males and females.  When tested in early adulthood females performed significantly more 
boxing and kicking and offensive sideways posture than males.  One possible reason for this 
finding is that females are considered to be more active than males (Archer, 1975).  Therefore 
increased aggressive behaviour may actually reflect increased activity.  While some 
differences were noted, for the most part, males and females performed similar rates of 
aggressive behaviour.   
 
6.2 Methodological Limitations 
To determine the degree to which the findings from this study can be generalized the 
limitations and strengths need to be considered.  One limitation of this study was the dose 
levels of methamphetamine used.  The dose used in the acute phase (2 mg/kg) was consistent 
with other research using methamphetamine (Herbert & Hughes, 2009; Johnson, 2010; 
McFadden & Matuszewich, 2007).  However, the dose used in the chronic phase (4 mg/kg) 
was less than what had been used in other research (Davidson, Lee & Ellinwood, 2004; 
Sovolov et al., 2004; Vorhees et al., 2004).  This may partially explain why increased 
aggression was not consistently found following the chronic dosing regimen.  
 
Another limitation of this study may have been the intraperitoneal route of administration 
used for methamphetamine and saline.  In humans, methamphetamine is commonly inhaled 
via smoke form therefore producing differences in rapidity and onset of drug action 
(Maxwell, 2005).  However, as both groups received i.p. exposure to saline or 
methamphetamine any alterations in behaviour should not be attributed to route of 
administration but to the effect of methamphetamine on behaviour.   
42 
 
A further limitation was that the same group of animals were used for both experimental 
groups, and therefore the teratological effects are the cumulative result of an acute and 
chronic dosing regimen combined.  As a result the adulthood outcome of an acute dosing 
regimen was not investigated. 
 
As with all animal studies, the issue arises of how well these results apply to humans.  This 
research was intended to be a preliminary study investigating the effects of methamphetamine 
use in adolescence.  Therefore to directly apply these results to humans further study is 
needed.   
 
6.3 Methodological Strengths 
The use of animals, and in particular rats, has several key advantages.  Rats develop much 
more quickly than humans do.  Rats reach periadolescence at PND 35 and adulthood at PND 
90 (Anderson, 2003).   This aging process made it possible to study the effects of 
methamphetamine across a large age span in a short period of time.  Animal models also 
allow for more control of possible effects of confounding variables.  In this study, the rats 
were housed in a contained environment in an animal facility.  This allowed for the 
elimination of extraneous factors that may have influenced the relationship between 
methamphetamine use and aggression.  These factors include, but are not limited to, drug 
concentration, time of drug administration, peer group, and parental practices (Weinberg et 
al., 1998).  Controlling for these confounding variables increases the likelihood that any 
behavioural effects are primarily due to methamphetamine exposure.  
 
A further strength of this study was the purity of the methamphetamine used.  
Methamphetamine is often produced by “cooks” in clandestine laboratories using over the 
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counter medication (ephedrine) and general household chemicals.  What is bought on the 
street as the end product is no longer pure methamphetamine and is instead mixed with a host 
of other ingredients and substances.  Therefore street methamphetamine varies substantially.  
This study used 90-100% pure crystal methamphetamine, donated from Environmental 
Science & Research Limited (ESR, Wellington, New Zealand).  Using pure 
methamphetamine ensures that the results of this study were due to methamphetamine and 
were not confounded by other ingredients or substances.  The use of pure methamphetamine 
also controlled for poly drug use.   
 
A further strength of this study is the use of an empirically supported measure of aggressive 
behaviour.  The resident intruder test has been effectively used to measure aggressive 
behaviour in a range of animals (Ferris et al., 1997; Johnson, 2010; Malkesman et al., 2006; 
Miczek, 1978; Miczek, & O‟Donnell, 1978; Ogawa et al., 1997; Sokolov & Cadet, 2006).   
 
6.4 Relationship to Previous Findings 
One of the findings from this research was that an acute dose of methamphetamine did not 
increase aggressive behaviour.  This is consistent with previous research.  Johnson (2010) 
exposed adolescent male rats to a single 1 mg/kg or 2 mg/kg of methamphetamine.  The 
animals were aged between PND 41-50 which is similar to adolescence in humans.  The 
animals were observed in the resident intruder test using a slightly different design to the one 
used in this study.  Of the eight behavioural measures used to assess aggressive behaviour, 
six indicated less aggressive behaviour in the methamphetamine group, and two indicated 
mixed findings.  Overall, the results showed that an acute dose of methamphetamine did not 
increase aggressive behaviour in male adolescent rats.  On the contrary, it may have reduced 
aggression.   
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Another finding from this study was that a chronic dosing regimen of methamphetamine did 
not clearly increase aggressive behaviour.  This is inconsistent with previous research.  
Sokolov, Schindler and Cadet (2004) exposed adult male mice to either an acute dosing 
regimen or chronic dosing regimen and then assessed aggressive behaviour using the resident 
intruder test.  In the acute regime mice were treated with a single 6 mg/kg injection of 
methamphetamine.  The chronic dosing regimen consisted of increasing twice daily injections 
over 8 weeks (up to 6 mg/kg each) of methamphetamine.  The study found no increase in 
aggressive behaviour following the acute administration, which is consistent with the findings 
from this study.  In contrast, chronic administration significantly increased the number of 
animals that initiated bite attacks and shortened the latency before the first attack.  These 
results indicate that chronic use of methamphetamine increases aggressive behaviour.   
 
One possible explanation for this inconsistency is the pattern of dosing and the dose of 
methamphetamine.  Sokolov and colleagues (2004) gradually increased the dose of 
methamphetamine in the chronic dosing regimen, mimicking more closely the increased dose 
of a chronic human user.  They also administered up to 6 mg/kg compared to the 4 mg/kg 
used in this study.  It is possible that a slightly higher dose of methamphetamine is 
responsible for the increase in aggressive behaviour. This may partially explain why, in the 
current research, there was a non significant trend towards increased aggression in the 
methamphetamine group.  Another explanation for the inconsistency was that their study 
used mice rather than rats.  It may be possible that the effect found in their study does not 
apply to rats.    
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Previous research indicates differences in the processing of drugs at different ages (Laviola et 
al., 1999).  Therefore, another explanation may be that the rats in the chronic administration 
group developed tolerance to the methamphetamine and thereby, repeated drug injections 
may have resulted in a reduction in the magnitude of the drug's effects (Laviola et al., 1999).   
The higher dose or gradually increasing dose used in previous research may have removed 
this effect.   
 
Another finding from this study was that chronic methamphetamine use in adolescence 
increased aggressive behaviour in adulthood.  This teratological effect is consistent with 
research suggesting methamphetamine is highly neurotoxic, in areas including the limbic 
system, dopamine system, and serotonin system (Barr et al., 2006).  Toxicities in these areas 
damage important physiological and behavioural systems that are responsible for regulating 
mood, anxiety, and behaviour including aggression.  
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7.0 Overall Discussion 
 
The findings from this research met some, but not all expectations.  An acute dosing regimen 
of methamphetamine in adolescence did not increase aggressive behaviour, thereby 
supporting previous research.  Overall, a chronic dosing regimen of methamphetamine during 
the adolescent period did not clearly increase aggressive behaviour.  This finding conflicts 
with previous research demonstrating increased aggression following a chronic dosing 
regimen.  Finally, methamphetamine use throughout adolescence increased aggressive 
behaviour in adulthood, following cessation of the drug.  This finding provides preliminary 
evidence for a teratological effect of methamphetamine.  The following section will discuss 
the theoretical significance, possible explanations for, and implications of these results.  
Finally, future directions for continuing research will be discussed.    
 
7.1 Neuronal Imprinting 
One aim of this study was to demonstrate neuronal imprinting of methamphetamine.  That is, 
it was expected that methamphetamine exposure throughout adolescence would produce 
detrimental effects well into in adulthood, following a sustained period of abstinence.  In 
support of the expectations, this study demonstrated methamphetamine exposure in 
adolescence significantly increased aggressiveness in adulthood.  This provides evidence for 
the theory. 
 
This finding suggests methamphetamine altered the development of particular brain regions 
where the drug was active.  As neurological analysis of the animals was not completed, it is 
unclear which brain regions were involved.  Methamphetamine is thought to increase levels 
of dopamine, norepinephrine, and serotonin (Homer et al., 2008).  It is suggested that 
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increased levels of these neurotransmitters in adolescence results in differing amount being 
produced in adulthood.  Research around the neurotoxicity of methamphetamine has 
suggested exposure influences the limbic system, including the hippocampus, grey matter, 
and corpus callosum (Barr et al., 2006).  It is proposed that adolescent exposure produces 
alterations in these brain regions and these persist into adulthood.  These changes to 
neurotransmitter systems and brain regions may combine to produce lasting differences in 
adulthood aggressive behaviour (Sekine et al., 2006).   
 
As mentioned previously, a reduction in serotonin is believed to influence aggressive 
behaviour (Sekine et al., 2006).  The results from this research suggest that increases in the 
serotonin system following methamphetamine exposure in adolescence may alter serotonin 
levels in adulthood thereby influencing aggression.   
 
7.2 Implications of Research and Application of Results 
The results from this research have substantial implications for society given the impact 
methamphetamine exposure may have on adolescents.  These results indicate that increasing 
the understanding of how methamphetamine affects behaviour may correct misguided 
assumptions about its use and have a positive influence on how adolescents choose to use and 
abuse drugs.  By dispelling the myth that a one-off dose of methamphetamine will produce 
profound and long lasting changes in behaviour society will gain a much clearer 
understanding of how the drug influences behaviour, especially when it is repeatedly used.   
 
Adolescence is a time marked by experimentation, sensation seeking, and risk taking 
behaviour.  As a result adolescents are often exposed to and use various substances. 
Substance use is particularly problematic during this time because it increases the risk of drug 
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use in adulthood and the risk of developing co morbid psychological disorders such as 
anxiety and mood disorders (Laviola et al., 1999; Stansfield & Kirstein, 2006).  It is also a 
period of ongoing neurodevelopment where the brain is undergoing a number of changes 
(Spear, 2007).   
 
Perhaps the strongest implication of this research is the teratological finding which suggests 
that while methamphetamine use during adolescence may not produce detrimental effects at 
the time of use, it will likely produce adult changes in aggressive behaviour.  This finding has 
major implications for New Zealand society given the financial and psychological cost that 
aggressive behaviour, crime, and mental health disorders pose.  This research supports the 
need for increased education and treatment programmes targeting adolescents.  
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8.0 Future Research 
 
To establish the relationship between methamphetamine and aggression the limitations of this 
study should be addressed.   Future studies should administer differing doses of 
methamphetamine in the chronic dosing regimen to establish whether aggression occurs in a 
dose-dependent manner. The use of a gradually increasing dosing regimen should also be 
used to mimic the pattern of human methamphetamine users more closely.  Future studies 
should also investigate different routes of administration and the possible effects this may 
have on the results.   
 
Possible initiatives that could be employed to improve future research include observing 
treated rats further into their development to establish how permanent the teratological effects 
are.  Neurological analysis of the treated animals would provide further information for the 
teratological and neurotoxic effects of methamphetamine exposure.  This could be done post 
mortem via examination of the brain.  Future research could investigate whether an acute 
dose of methamphetamine has any teratological effects by administering acute and chronic 
doses to different groups.  
 
In future in would be useful to video record testing in the resident intruder test.  This would 
allow a re-examination of responses as to ensure recording was correct.  These recordings 
could also be examined by a third party to ensure inter-rater reliability.  Future research 
should measure boxing and kicking as two separate aggressive behaviours.  This follows the 
current literature on rat behaviour and is consistent with the observations from this research.  
When compared to all other aggressive behaviours measured in this study the effect that 
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methamphetamine exposure had on boxing and kicking behaviour was less clear.  The 
separation of these two behaviours in future research may assist in clarifying this.    
 
The current lack of literature surrounding the effects of adolescent drug use should be 
addressed.  Particular focus on this age group is essential as adolescence is a developmental 
period where drug experimentation is common and the developing brain is undergoing a 
number of changes.  This research has provided preliminary evidence for a delayed effect of 
methamphetamine in adulthood but more research needs to be conducted to understand this 
relationship more clearly.  It is important that research around drug exposure across the 
adolescent period of development continues.   
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9.0 Conclusions 
 
The results from this research conclude that an acute dose of methamphetamine during 
adolescence does not increase aggressive behaviour.  A chronic dosing regimen of 
methamphetamine throughout adolescence may increase the likelihood of some aggressive 
behaviour but overall it does not appear to increase aggression.  This research also concluded 
that methamphetamine use throughout adolescence, and following cessation, increases 
aggressive behaviour in adulthood.   
 
Methamphetamine has been strongly linked to aggressive behaviour and is often associated 
with violent crime.  This research provides further information that can assist in 
understanding this relationship.  This research also highlights the risks associated with 
methamphetamine use in adolescence, and provides support for increased education and/or 
treatment services targeting this age group. Overall, it appears that a one-off use of 
methamphetamine or ongoing use of a relatively small dose may not increase aggressive 
behaviour. However, more notably, it influences behaviour in adulthood following a long 
period of no drug use.  This finding provides support the neuronal imprinting theory.   
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